PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
January 1, 2020Journal of Family Medicine and Primary Care133 citationsOpen Access

Trends in FDA drug approvals over last 2 decades: An observational study

View Full Paper
BKBhupinder Singh KalraABAngelika BattaRKRaj Khirasaria

Key Points

  • This research aims to analyze trends in FDA drug approvals over the past two decades, focusing on various therapeutic areas.
  • Analyzed drug approval data from CDER over 20 years.
  • Compared approval rates of anticancer and biologics with drugs for neurological and lifestyle diseases.
  • Steady rate of new drug introductions by CDER over two decades observed.
  • Increased expedited approvals for anticancer drugs and biologics identified.
  • Slower progress noted in approvals for neurological disorders and lifestyle diseases.

Abstract

There has been a steady rate of introduction of new drugs by CDER over the last two decades. Expedited approval of anticancer and biologics is seen as recent trend in drug development. Relatively, slow progress in approval of drugs for neurological disorders (depression, psychosis, multiple sclerosis, etc.) and lifestyle diseases like obesity, atherosclerosis, diabetes, etc., were seen. These findings reflect more emphasis being laid down in research for anticancer drugs and biologics.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Kalra et al. (2020) studied this question.

synapsesocial.com/papers/69dff6b31827a1d0b1255919https://doi.org/10.4103/jfmpc.jfmpc_578_19
Ask AI
Helpful
Bookmark
Share
View Full Paper

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Association of the FDA Amendment Act with trial registration, publication, and outcome reporting2017 · 64 citations
  2. 2Update on Novel Drugs for Primary Care Practice: Drugs Approved by the U.S. Food and Drug Administration in 20152016 · 1 citations
  3. 3Expediting Drug Development: FDA’s New Regenerative Medicine Advanced Therapy Designation2018 · 39 citations
  4. 4Food and Drug Administration Drug Approval Process2016 · 29 citations
  5. 52016 FDA drug approvals2017 · 122 citations